Walther, T; Schuler, G; Borger, M A; Kempfert, J; Seeburger, J; Rückert, Y; Ender, J; Linke, A; Scholz, M; Falk, V; Mohr, F W (2010). Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. European Heart Journal, 31(11):1398-1403.
Full text not available from this repository.
AIMS: To evaluate the outcome of transapical aortic valve implantation (TA-AVI) in comparison to conventional surgery.
METHODS AND RESULTS: One hundred consecutive high-risk patients with symptomatic aortic valve stenosis received TA-AVI using the Edwards SAPIEN pericardial xenograft between February 2006 and January 2008. Patient age was 82.7 +/- 5 years, 77 were females, logistic EuroSCORE predicted risk of mortality was 29.4 +/- 13% and Society Thoracic Surgeons score risk for mortality was 15.2 +/- 8.3%. Propensity score analysis was used to identify a control group of patients that underwent conventional aortic valve replacement (C-AVR). Transapical aortic valve implantation was performed successfully in 97 patients, whereas three patients required early conversion. There were no new onset neurological events in the TA-AVI group and early extubation was performed in 82 patients. Echocardiography revealed good valve function with low transvalvular gradients in all patients. Thirty-day survival was 90 +/- 3 vs. 85 +/- 4% for TA-AVI vs. C-AVR, and 1-year survival was 73 +/- 4 vs. 69 +/- 5% (P = 0.55).
CONCLUSION: Transapical aortic valve implantation is a safe, minimally invasive, and off-pump technique to treat high-risk patients with aortic stenosis. Results of the initial 100 patients are good and compare favourably to conventional surgery.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiovascular Surgery|
|DDC:||610 Medicine & health|
|Deposited On:||07 Jan 2011 14:25|
|Last Modified:||23 Nov 2012 16:17|
|Publisher:||Oxford University Press|
|Free access at:||PubMed ID. An embargo period may apply.|
|WoS Citation Count:||44|
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page